Evaluation of Dabigatran Bleeding Adverse Reaction Reports in the FDA Adverse Event Reporting System during the First Year of Approval

Hospitalized patients with atrial fibrillation compared to those included in recent trials on novel oral anticoagulants: A population-based study

(2013) R. Joppi et al.   European Journal of Internal Medicine

Dabigatran versus Warfarin in Patients with Mechanical Heart Valves

(2013) John W. Eikelboom et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dabigatran and Postmarketing Reports of Bleeding

(2013) Mary Ross Southworth et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study

(2013) Rikke Sørensen et al.   BMJ Open

Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) Versus Warfarin in Patients With Atrial Fibrillation

(2012) Corey S. Miller et al.   AMERICAN JOURNAL OF CARDIOLOGY

National Trends in Oral Anticoagulant Use in the United States, 2007 to 2011

(2012) Kate Kirley et al.  

Bleeding Risk with Dabigatran in the Frail Elderly

(2012) Paul Harper et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neurosurgical Implications of Dabigatran-Associated Intracerebral Hemorrhage

(2012) Robert M. Starke et al.   World Neurosurgery

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation

(2011) John W. Eikelboom et al.   CIRCULATION

Acutely Injured Patients on Dabigatran

(2011) Bryan A. Cotton et al.   NEW ENGLAND JOURNAL OF MEDICINE

Emergency Hospitalizations for Adverse Drug Events in Older Americans

(2011) Daniel S. Budnitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Correction of coagulopathy in warfarin associated cerebral hemorrhage

(2009) Venkatesh Aiyagari et al.   Current Opinion in Critical Care

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE